Researchers design compounds that prevent SARS-CoV-2 entry in human lung cells

By | May 11, 2021
Researchers have designed a new class of TMPRSS2 inhibitors that have shown broad antiviral activity against coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).